Apropeau SRL
Apropeau reported total assets of 1,902 € at the end of the 2024 financial year (annual accounts filed with the NBB on 24 Jul 2025).
The score of Apropeau shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2024
Change 2021 → 2024: Total assets -29 %
Accounts of the company itself (not consolidated).
The full file covers 8 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Apropeau's annual accounts
Filed annual accounts
- Year ended 31 Dec 2024filed on 24 Jul 2025
- Year ended 31 Dec 2023filed on 24 Jun 2024
- Year ended 31 Dec 2022filed on 26 Jun 2023
- Year ended 31 Dec 2021filed on 20 Jun 2022
- Year ended 31 Dec 2020filed on 28 Jun 2021
Apropeau's financial analysis
- Solvency-1416.9%sector median: 46.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Apropeau
Apropeau's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0663.881.361
- VAT number
- BE0663881361
- Peppol
- Registered · 0208:0663881361 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 06 Oct 2016
- Registered office
- 3001 Leuven
- Latest accounts
- 2024 · filed on 24 Jul 2025
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
Apropeau (SRL) has been based in Leuven since 2016, active in: wholesale of pharmaceutical and medical goods. For 2024, it reports a net loss of 3,756 € and equity of −26,951 €; its revenue is not published. Its solvency stands at -1416.9%, below the median of its sector (46.0%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Apropeau
Companies in the same business, of comparable size and area, outside its group.
- Avanott Wholesale of pharmaceutical and medical goods Herent · balance sheet 127,081 €
- Linden API Wholesale of pharmaceutical and medical goods Ixelles · balance sheet 12,520 €
- Cirba Wholesale of pharmaceutical and medical goods Ixelles · balance sheet 67,062 €
- Isotope Service Belux Wholesale of pharmaceutical and medical goods Hoogstraten · balance sheet 3,213 €
- Recurex Retail sale of pharmaceutical products Overijse · balance sheet 3,342 €
- Belderm Wholesale of pharmaceutical and medical goods Woluwe-Saint-Lambert · balance sheet 7,299 €
- Prothéses d'Oreille Utilitaires dans la Recherche et la Technologie Wholesale of pharmaceutical and medical goods Manage · balance sheet 17,598 €
- Smartvalue Distribution Wholesale of pharmaceutical and medical goods Liège · balance sheet 56,516 €
Frequently asked questions about Apropeau
What is the revenue of Apropeau?
Apropeau files its accounts in a format where revenue is optional: it is not published for 2024.
What is the VAT number of Apropeau?
In Belgium, the VAT number is the company number prefixed with BE: BE0663881361 for Apropeau, if the company is VAT-registered. Its company number (CBE) is 0663.881.361.
Where is the registered office of Apropeau?
According to the CBE register, the registered office of Apropeau is in 3001 Leuven.
What is the equity of Apropeau?
At the close of the 2024 financial year, the equity of Apropeau amounts to -26,951 €, a solvency of -1416.9% of total assets.
Who manages Apropeau?
The register lists 2 active mandates at Apropeau. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Apropeau
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →